Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2001;86:250-252; doi:10.1136/heart.86.3.250
Copyright © 2001 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2001;86:250-252 ( September )

Journal scan

The first 150 words of the full text of this article appear below.

    JOURNALSCAN

Please visit the Heart website (www.heartjnl.com) for links to these articles---many to full text.

IQBAL MALIK

Editor, JournalScan


    ISCHAEMIC HEART DISEASE

Bored with PTCA? What about carotid stenting? The more adventurous interventionalist is always on the lookout for a new procedure. The Lancet offers what looks like equivalence at three years for carotid endarterectomy and angioplasty (with a 30% stent rate). However, the combined major stroke/death rate was 10% in both groups at 30 days, higher than 6.5% in the NASCET trial and 7.0% in the ECST trial. In addition, there was no medically treated control group. One could reason that the reason for equivalence (with wide confidence intervals) was that surgery did not produce the benefits expected. The rule has to be that the surgeon has to have a low rate of stroke/death at 30 days to consider surgery a good option over medical treatment, and that angioplasty at present should . . . [Full text of this article]

This Article

Services
Citing Articles
Google Scholar

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.